Identification of a Novel Subtype-Selective α1B-Adrenoceptor Antagonist.
Ontology highlight
ABSTRACT: α1A-, α1B-, and α1D-adrenoceptors (α1-ARs) are members of the adrenoceptor G protein-coupled receptor family that are activated by adrenaline (epinephrine) and noradrenaline. α1-ARs are clinically targeted using antagonists that have minimal subtype selectivity, such as prazosin and tamsulosin, to treat hypertension and benign prostatic hyperplasia, respectively. Abundant expression of α1-ARs in the heart and central nervous system (CNS) makes these receptors potential targets for the treatment of cardiovascular and CNS disorders, such as heart failure, epilepsy, and Alzheimer's disease. Our understanding of the precise physiological roles of α1-ARs, however, and their involvement in disease has been hindered by t
SUBMITTER: Abdul-Ridha A
PROVIDER: S-EPMC10854767 | biostudies-literature | 2024 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA